tiprankstipranks
Trending News
More News >
XTL Biopharmaceuticals Ltd. (IL:XTLB)
:XTLB
Israel Market
Advertisement

Xtl Bio (XTLB) Financial Statements

Compare
0 Followers

Xtl Bio Financial Overview

Xtl Bio's market cap is currently 35.26M. The company's EPS TTM is -0.005; its P/E ratio is ―; Xtl Bio is scheduled to report earnings on ―, and the estimated EPS forecast is ―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Currency in USD

Xtl Bio Earnings and Revenue History

Xtl Bio Debt to Assets

Xtl Bio Cash Flow

Xtl Bio Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis